California 2019-2020 Regular Session

California Assembly Bill AB1723

Introduced
2/22/19  
Refer
3/18/19  
Refer
3/18/19  
Report Pass
3/18/19  
Report Pass
3/18/19  
Refer
3/19/19  
Report Pass
4/10/19  
Report Pass
4/10/19  
Refer
4/10/19  
Refer
4/10/19  
Report Pass
4/24/19  
Report Pass
4/24/19  
Refer
4/24/19  
Refer
4/24/19  
Report Pass
5/1/19  
Report Pass
5/1/19  
Engrossed
5/9/19  
Engrossed
5/9/19  
Refer
5/9/19  
Refer
5/22/19  
Refer
5/22/19  
Report Pass
6/10/19  
Report Pass
6/10/19  
Refer
6/10/19  
Refer
6/10/19  
Enrolled
9/6/19  
Enrolled
9/6/19  
Chaptered
9/20/19  
Chaptered
9/20/19  
Passed
9/20/19  

Caption

Pharmacy: clinics: purchasing drugs at wholesale.

Impact

The bill primarily impacts community and free clinics, as well as clinics operated by counties and Indian tribes, which are now permitted to operate longer hours. By increasing clinic hours, the legislation is anticipated to improve patient access to essential medications. The update to the regulations is seen as a step towards alleviating some of the constraints that limit clinics' capabilities to serve their communities, ultimately benefiting underserved populations.

Summary

Assembly Bill No. 1723, authored by Wood, amends Section 4180 of the Business and Professions Code to allow specified clinics to purchase drugs at wholesale for administration or dispensing to registered patients. Previously, certain clinics could operate for no more than 20 hours a week, but this bill expands their allowable operating hours to up to 40 hours a week. This change aims to enhance healthcare access by enabling clinics to serve patients for a longer duration while maintaining compliance with pharmacy regulations.

Sentiment

General sentiment surrounding AB 1723 appears positive among healthcare providers and advocates for increased access to healthcare services. Stakeholders recognize the potential benefits for patients, especially in underserved areas where access to healthcare resources can be limited. However, some concern may exist regarding the administrative burden placed on clinics to manage the new regulations effectively, ensuring compliance while expanding their operational hours.

Contention

While the bill benefits various health entities, there may be concerns regarding the quality of care and oversight of drug purchasing practices as clinics increase their operating hours. Balancing the need for wider access to medications with the responsibility to maintain high standards of patient care and regulatory compliance is crucial. Ensuring clinics have adequate resources and training to adhere to these updates is essential for the successful implementation of the provisions outlined in AB 1723.

Companion Bills

No companion bills found.

Similar Bills

CA AB2115

Controlled substances: clinics.

CT SB00706

An Act Concerning Epinephrine Auto Injectors.

CA AB1468

Opioid Prevention and Rehabilitation Act.

CA AB1533

Pharmacy.

CA AB315

Pharmacy benefit management.

CA AB915

Pupil health: drug education: opioid overdose training program.

CT HB05384

An Act Concerning Prescription Drug Costs.

VA HB1724

Prescription Drug Affordability Board; established, drug cost affordability review, report.